The Economic Impact of SARS

Default product image

The Economic Impact of SARS

Business and Household Indicators Canadian Economic Analysis Health and Healthcare Urban City Economic Analysis
Pages:3 pages5 min read

Author: Paul M. Darby

$425.00

Signal49 Research’s Canadian Tourism Research Institute (CTRI) has analyzed the impact of SARS on all aspects of business and leisure travel for both Toronto and Canada as a whole. In addition, using its economic model for Toronto, Signal49 Research has estimated the losses from SARS on Toronto’s GDP, including induced effects.

Want a discount? Become a member by purchasing a subscription! Learn More

Signal49 Research’s Canadian Tourism Research Institute (CTRI) has analyzed the impact of SARS on all aspects of business and leisure travel for both Toronto and Canada as a whole. In addition, using its economic model for Toronto, Signal49 Research has estimated the losses from SARS on Toronto’s GDP, including induced effects.

Document Highlights

The outbreak of SARS in Canada is forecast to lower real GDP by approximately $1.5 billion,or 0.15 per cent,in 2003.

Roughly two-thirds of this impact will be felt by the City of Toronto,lowering its real GDP by 0.5 per cent this year.

Tourism receipts in Toronto are forecast to be lower by 8.9 per cent this year as a direct result of SARS, not counting a substantial drop in activity at Pearson International Airport.

By far, the largest impact of SARS is felt in the travel and tourism industry, which nationally is expected to lose about $1.1 billion in real economic activity in 2003.

Questions?

Call 1-888-801-8818 or send us a message (Mon–Fri: 8 am to 5 pm).

This field is hidden when viewing the form
This field is hidden when viewing the form

Require an accessible version of this research?

Upon request, Signal49 Research offers accessible versions of research. Please contact us to request your accessible version.

Learn more about our accessibility policies.

Reviews

Be the first to review “The Economic Impact of SARS”

There are no reviews yet.